Biostax Corp (BTAX)

[locicat1]

Have you purchased and downloaded the article? If so you will find that it is a short (4 and 1/2 pages) summary article with 111 References. It was written by Fengping Shan and his colleagues at China Medical University, Shenyang, China. Name seem familiar-it should-Shan is the apparently unpaid (according to the latest IMUN SEC filings)CSO (Chief Scientific Officer) of IMUN. The addition of Griffin on this (as well as other publications by Shan) is laughable.

Even though there is definite technical information within this summary that may make difficult reading for some, in general this article SHOULD be read by all shareholders. I firmly believe this is the promised "Scientific White Paper" that was to be completed by the end of 2017 as stated by Griffin in her November 30, 2017 Shareholder Letter and should be made immediately available to all shareholders.